0001104659-07-054398.txt : 20070717 0001104659-07-054398.hdr.sgml : 20070717 20070717145311 ACCESSION NUMBER: 0001104659-07-054398 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20070711 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20070717 DATE AS OF CHANGE: 20070717 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MEDQUIST INC CENTRAL INDEX KEY: 0000884497 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROCESSING & DATA PREPARATION [7374] IRS NUMBER: 222531298 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-19941 FILM NUMBER: 07983950 BUSINESS ADDRESS: STREET 1: FIVE GREENTREE CENTRE STE 311 STREET 2: STATE HIGHWAY 73 N CITY: MARLTON STATE: NJ ZIP: 08053 BUSINESS PHONE: 8568108000 MAIL ADDRESS: STREET 1: 5 GREENTREE CENTRE SUITE 311 STREET 2: ATTN BRUCE VAN FOSSEN CITY: MARLTON STATE: NJ ZIP: 08053 8-K 1 a07-19674_18k.htm 8-K

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 11, 2007

MedQuist Inc.
(Exact name of registrant as specified in charter)

New Jersey	0-19941	22-2531298
(State or other jurisdiction	(Commission	(I.R.S. Employer
of incorporation)	File Number)	Identification No.)

1000 Bishops Gate Blvd., Suite 300, Mt. Laurel, NJ		08054
(address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (856) 206-4000

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01 Other Events.

On July 11, 2007, MedQuist Inc. (the “Company”) announced that, at the direction of the Company’s Board of Directors (the “Board”), the Company has engaged Bear, Stearns & Co. Inc. to advise the Company and the Board on strategic alternatives for the Company. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein solely for purposes of this Item 8.01 disclosure.

Item 9.01. Financial Statements and Exhibits.

The following exhibit is filed with this Form 8-K:

Exhibit No.		Description
99.1		Press Release dated July 11, 2007

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	MEDQUIST INC.

Date: July 17, 2007	By:	/s/ Mark R. Sullivan
		Name: Mark R. Sullivan
		Title: General Counsel and Chief Compliance Officer

EXHIBIT INDEX

Exhibit No.		Description
99.1		Press Release dated July 11, 2007

EX-99.1 2 a07-19674_1ex99d1.htm EX-99.1

Exhibit 99.1

MedQuist Announces Engagement of Bear, Stearns & Co. Inc. to Provide Advice on Strategic Alternatives

MT. LAUREL, N.J.—(BUSINESS WIRE)—July 11, 2007—MedQuist Inc. (Pink Sheets: MEDQ.PK) announces that, at the direction of the Company’s Board of Directors, the Company has engaged Bear, Stearns & Co. Inc. to advise the Company and the Board on strategic alternatives for the Company. There is no assurance that any transaction or change in strategic direction will occur as a result of the Company’s review of strategic alternatives.

About MedQuist:

MedQuist is the leading provider of medical transcription technology and services, which are integral to the clinical documentation workflow. MedQuist services health systems, hospitals and large group medical practices throughout the U.S., and MedQuist employs approximately 6,300 skilled medical transcriptionists (MTs), making it the largest employer of MTs in the U.S. In the clinical documentation workflow, MedQuist provides, in addition to medical transcription technology and services, digital dictation, speech recognition, electronic signature and medical coding technology and services. MedQuist is a member of the Philips Group of Companies and collaborates with Philips Medical Systems in marketing and product development to leverage Philips’ technology and professional expertise to deliver industry-leading solutions for its customers.

“Safe Harbor” Statement under the U.S. Private Securities Litigation Reform Act of 1995: Statements in this press release regarding MedQuist’s business which are not historical facts are “forward-looking statements” that involve risks and uncertainties, including without limitation that the Company’s review of strategic alternatives, even as assisted by the engagement of Bear, Stearns & Co. Inc., may not result in any transaction or change in strategic direction, and that any strategic alternative reviewed by the Company may not be attractive to shareholders and may not result in enhanced shareholder value. Actual outcomes and results may differ materially from what is expressed or forecasted in forward-looking statements. As a result, forward-looking statements speak only as of the date they were made, and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Web site: http://www.medquist.com

CONTACT: For MedQuist Inc.

Feinstein Kean Healthcare
Craig Martin, 617-761-6729
craig.martin@fkhealth.com

SOURCE: MedQuist Inc.